Financhill
Back

Solid Biosciences Quote, Financials, Valuation and Earnings

Solid Biosciences Price Quote

$5.53
-0.21 (-3.66%)
(Updated: October 31, 2024 at 6:55 PM ET)

Solid Biosciences Key Stats

Sell
17
Solid Biosciences (SLDB) is a Sell

Day range:
$5.65 - $5.99
52-week range:
$2.00 - $15.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
11.51
P/B ratio:
1.14%

Volume:
225.8K
Avg. volume:
298.8K
1-year change:
177.29%
Market cap:
$220M
Revenue:
$0
EPS:
$-3.3

How Much Does Solid Biosciences Make?

Data Unavailable

Is Solid Biosciences Growing As A Company?

Data Unavailable

Solid Biosciences Stock Price Performance

  • Did Solid Biosciences Stock Go Up Last Month?
    Solid Biosciences share price went down by -17.65% last month
  • Did SLDB's Share Price Rise Over The Last Year?
    SLDB share price rose by 177.29% over the past 1 year

What Is Solid Biosciences 52-Week High & Low?

Solid Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Solid Biosciences?

  • How Much Debt Does Solid Biosciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Solid Biosciences Have?
    Cash and short term investments quarterly total is $190.3M
  • What Is Solid Biosciences’s Book Value Per Share?
    Book value per share is 5.01

Is Solid Biosciences Cash Flow Positive?

  • What Is SLDB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$85.4M
  • What Is Solid Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $112.7M
  • What Is Solid Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$23M

Solid Biosciences Return On Invested Capital

Data Unavailable

Solid Biosciences Earnings Date & Stock Price

Solid Biosciences Competitors

  • Who Are Solid Biosciences's Competitors?
    Below is a list of companies who compete with Solid Biosciences or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • Electromed Inc (ELMD)
    • Myomo Inc (MYO)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

Solid Biosciences Dividend Yield

Solid Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.86%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 18.00
Upside from Last Price: 213.59%

Major Shareholders

  • How many SLDB shares are owned by institutional investors?
    46.1M SLDB shares are owned by institutional investors
  • How many SLDB shares are owned by insiders?
    8.1M SLDB shares are owned by insiders